The RNA modification landscape in human disease

RNA

Volumn 23, Issue 12, 2017, Pages 1754-1769

  Jonkhout, Nicky ^a,b   Tran, Julia ^a   Smith, Martin A ^a,b   Schonrock, Nicole ^a,c   Mattick, John S ^a,b   Novoa, Eva Maria ^a,b,d,e  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Genome One   (Australia)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^e BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

Detection methods; Direct RNA sequencing; Disease; Epitranscriptome; RNA modification

Indexed keywords

RIBOSOME RNA; SMALL NUCLEOLAR RNA; TRANSCRIPTOME; TRANSFER RNA; RNA;

CELL DIFFERENTIATION; GENE MAPPING; GENETIC DISORDER; GENETIC PROCEDURES; HUMAN; MALIGNANT NEOPLASM; NEUROLOGIC DISEASE; PRIORITY JOURNAL; REVIEW; RNA MODIFICATION; RNA SEQUENCE; SEX DETERMINATION; ANIMAL; CHEMISTRY; DISEASES; GENETICS; RNA PROCESSING;

ANIMALS; DISEASE; HUMANS; RNA; RNA PROCESSING, POST-TRANSCRIPTIONAL;

EID: 85031782913     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.063503.117     Document Type: Review

References (144)

1. Abbasi-Moheb L, Mertel S, Gonsior M, Nouri-Vahid L, Kahrizi K, Cirak S, Wieczorek D, Motazacker MM, Esmaeeli-Nieh S, Cremer K, et al. 2012. Mutations in NSUN2 cause autosomal-recessive intellectual disability. Am J Hum Genet 90: 847-855.
2. Addepalli B, Limbach PA. 2011. Mass spectrometry-based quantification of pseudouridine in RNA. J Am Soc Mass Spectrom 22: 1363-1372.
3. Agris PF, Narendran A, Sarachan K, Väre VYP, Eruysal E. 2017. The importance of being modified: the role of RNA modifications in trans-lational fidelity. Enzymes 41: 1-50.
4. Alings F, Sarin LP, Fufezan C, Drexler HC, Leidel SA. 2015. An evolutionary approach uncovers a diverse response of tRNA 2-thiolation to elevated temperatures in yeast. RNA 21: 202-212.
5. Armistead J, Khatkar S, Meyer B, Mark BL, Patel N, Coghlan G, Lamont RE, Liu S, Wiechert J, Cattini PA, et al. 2009. Mutation of a gene essential for ribosome biogenesis, EMG1, causes Bowen-Conradi syndrome. Am J Hum Genet 84: 728-739.
6. Aviran S, Pachter L. 2014. Rational experiment design for sequencing-based RNA structure mapping. RNA 20: 1864-1877.
7. 6A RNA modification controls cell fate transition in mammalian embryonic stem cells. Cell Stem Cell 15: 707-719.
8. Bednárová A, Hanna M, Durham I, VanCleave T, England A, Chaudhuri A, Krishnan N. 2017. Lost in translation: defects in transfer RNA modifications and neurological disorders. Front Mol Neurosci 10: 135.
9. Begley U, Sosa MS, Avivar-Valderas A, Patil A, Endres L, Estrada Y, Chan CT, Su D, Dedon PC, Aguirre-Ghiso JA, et al. 2013. A human tRNA methyltransferase 9-like protein prevents tumour growth by regulating LIN9 and HIF1-α. EMBO Mol Med 5: 366-383.
10. Behm M, Öhman M. 2016. RNA editing: a contributor to neuronal dynamics in the mammalian brain. Trends Genet 32: 165-175.
11. Benrahma H, Charoute H, Lasram K, Boulouiz R, Atig RK, Fakiri M, Rouba H, Abdelhak S, Barakat A. 2014. Association analysis of IGF2BP2, KCNJ11, and CDKAL1 polymorphisms with type 2 diabetes mellitus in a Moroccan population: a case-control study and meta-analysis. Biochem Genet 52: 430-442.
12. Blanco S, Dietmann S, Flores JV, Hussain S, Kutter C, Humphreys P, Lukk M, Lombard P, Treps L, Popis M, et al. 2014. Aberrant meth-ylation of tRNAs links cellular stress to neuro-developmental disorders. EMBO J 33: 2020-2039.
13. Boža V, Brejová B, Vinar T. 2017. DeepNano: deep recurrent neural networks for base calling in MinION nanopore reads. PLoS One 12: e0178751.
14. Cantara WA, Crain PF, Rozenski J, McCloskey JA, Harris KA, Zhang X, Vendeix FA, Fabris D, Agris PF. 2011. The RNA Modification Database, RNAMDB: 2011 update. Nucleic Acids Res 39: D195-D201.
15. Carlile TM, Rojas-Duran MF, Zinshteyn B, Shin H, Bartoli KM, Gilbert WV. 2014. Pseudouridine profiling reveals regulated mRNA pseudouridylation in yeast and human cells. Nature 515: 143-146.
16. Cattenoz PB, Taft RJ, Westhof E, Mattick JS. 2013. Transcriptome-wide identification of A > I RNA editing sites by inosine specific cleavage. RNA 19: 257-270.
17. Chan CT, Dyavaiah M, DeMott MS, Taghizadeh K, Dedon PC, Begley TJ. 2010. A quantitative systems approach reveals dynamic control of tRNA modifications during cellular stress. PLoS Genet 6: e1001247.
18. Chen D, Patton JT. 2001. Reverse transcriptase adds nontemplated nu-cleotides to cDNAs during 5′-RACE and primer extension. Biotechniques 30: 574-580, 582.
19. Chen CX, Cho DS, Wang Q, Lai F, Carter KC, Nishikura K. 2000. A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains. RNA 6: 755-767.
20. Chen Q, Yan M,CaoZ,Li X, ZhangY, Shi J, Feng GH, Peng H,Zhang X, Zhang Y, et al. 2016. Sperm tsRNAs contribute to intergenerational inheritance of an acquired metabolic disorder. Science 351: 397-400.
21. Chi L, Delgado-Olguin P. 2013. Expression of NOL1/NOP2/sun domain (Nsun) RNA methyltransferase family genes in early mouse embryogenesis. Gene Expr Patterns 13: 319-327.
22. Claussnitzer M, Dankel SN, Kim KH, Quon G, Meuleman W, Haugen C, Glunk V, Sousa IS, Beaudry JL, Puviindran V, et al. 2015. FTO obesity variant circuitry and adipocyte browning in humans. N Engl J Med 373: 895-907.
23. Cretu Stancu M, van Roosmalen MJ, Renkens I, Nieboer M, Middelkamp S, de Ligt J, Pregno G, Giachino D, Mandrile G, Espejo Valle-Inclan J, et al. 2017. Mapping and phasing of structural variation in patient genomes using nanopore sequencing. bioRxiv. doi: 10.1101/129379
24. Davarniya B, Hu H, Kahrizi K, Musante L, Fattahi Z, Hosseini M, Maqsoud F, Farajollahi R, Wienker TF, Ropers HH, et al. 2015. The role of a novel TRMT1 gene mutation and rare GRM1 gene defect in intellectual disability in two Azeri families. PLoS One 10: e0129631.
25. David M, Dursi LJ, Yao D, Boutros PC, Simpson JT. 2017. Nanocall: an open source basecaller for Oxford Nanopore sequencing data. Bioinformatics 33: 49-55.
26. Day JJ, Childs D, Guzman-Karlsson MC, Kibe M, Moulden J, Song E, Tahir A, Sweatt JD. 2013. DNA methylation regulates associative reward learning. Nat Neurosci 16: 1445-1452.
27. Dedon PC, Begley TJ. 2014. A system of RNA modifications and biased codon use controls cellular stress response at the level of translation. Chem Res Toxicol 27: 330-337.
28. Delatte B, Wang F, Ngoc LV, Collignon E, Bonvin E, Deplus R, Calonne E, Hassabi B, Putmans P, Awe S, et al. 2016. RNA biochemistry. Transcriptome-wide distribution and function of RNA hydroxymethylcytosine. Science 351: 282-285.
29. Delaunay S, Rapino F, Tharun L, Zhou Z, Heukamp L, Termathe M, Shostak K, Klevernic I, Florin A, Desmecht H, et al. 2016. Elp3 links.tRNA modification to IRES-dependent translation of LEF1 to sustain metastasis in breast cancer. J Exp Med 213: 2503-2523.
30. Deng W, Babu IR, Su D, Yin S, Begley TJ, Dedon PC. 2015. Trm9-catalyzed tRNA modifications regulate global protein expression by codon-biased translation. PLoS Genet 11: e1005706.
31. Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F, et al. 2012. Landscape of transcription in human cells. Nature 489: 101-108.
32. Doll A, Grzeschik KH. 2001. Characterization of two novel genes, WBSCR20 and WBSCR22, deleted in Williams-Beuren syndrome. Cytogenet Cell Genet 95: 20-27.
33. 6A-seq. Nature 485: 201-206.
34. 1-methyladenosine methylome in eukary-otic messenger RNA. Nature 530: 441-446.
35. 6A genes with major depressive disorder in Chinese Han population. J Affect Disord 183: 279-286.
36. Fahiminiya S, Almuriekhi M, Nawaz Z, Staffa A, Lepage P, Ali R, Hashim L, Schwartzentruber J, Abu Khadija K, Zaineddin S, et al. 2014. Whole exome sequencing unravels disease-causing genes in consanguineous families in Qatar. Clin Genet 86: 134-141.
37. Franke B, Vermeulen SH, Steegers-Theunissen RP, Coenen MJ, Schijvenaars MM, Scheffer H, den Heijer M, Blom HJ. 2009. An association study of 45 folate-related genes in spina bifida: Involvement of cubilin (CUBN) and tRNA aspartic acid methyltrans-ferase 1 (TRDMT1). Birth Defects Res A Clin Mol Teratol 85: 216-226.
38. Freude K, Hoffmann K, Jensen LR, Delatycki MB, des Portes V, Moser B, Hamel B, van Bokhoven H, Moraine C, Fryns JP, et al. 2004. Mutations in the FTSJ1 gene coding for a novel S-adenosylme-thionine-binding protein cause nonsyndromic X-linked mental retardation. Am J Hum Genet 75: 305-309.
39. Frye M, Jaffrey SR, Pan T, Rechavi G, Suzuki T. 2016. RNA modifications: what have we learned and where are we headed? Nat Rev Genet 17: 365-372.
40. Fustin JM, Doi M, Yamaguchi Y, Hida H, Nishimura S, Yoshida M, Isagawa T, Morioka MS, Kakeya H, Manabe I, et al. 2013. RNA-methylation-dependent RNA processing controls the speed of the circadian clock. Cell 155: 793-806.
41. Gaisler-Salomon I, Kravitz E, Feiler Y, Safran M, Biegon A, Amariglio N, Rechavi G. 2014. Hippocampus-specific deficiency in RNA editing of GluA2 in Alzheimer's disease. Neurobiol Aging 35: 1785-1791.
42. Garalde DR, Snell EA, Jachimowicz D, Heron AJ, Bruce M, Lloyd J, Warland A, Pantic N, Admassu T, Ciccone J, et al. 2016. Highly parallel direct RNA sequencing on an array of nanopores. bioRxiv. doi: 10.1101/068809.
43. Gilbert WV, Bell TA, Schaening C. 2016. Messenger RNA modifications: form, distribution, and function. Science 352: 1408-1412.
44. Grice LF, Degnan BM. 2015. The origin of the ADAR gene family and animal RNA editing. BMC Evol Biol 15: 4.
45. Grosjean H. 2015. RNA modification: the Golden Period 1995-2015. RNA 21: 625-626.
46. 2U modification in yeast. RNA 21: 188-201.
47. Hauenschild R, Tserovski L, Schmid K, Thuring K, Winz ML, Sharma S, Entian KD, Wacheul L, Lafontaine DL, Anderson J, et al. 2015. The reverse transcription signature of N-1-methyladenosine in RNA-Seq is sequence dependent. Nucleic Acids Res 43: 9950-9964.
48. 6A potentiates Sxl alternative pre-mRNA splicing for robust Drosophila sex determination. Nature 540: 301-304.
49. He C. 2010. Grand challenge commentary: RNA epigenetics? Nat Chem Biol 6: 863-865.
50. Helm M, Alfonzo JD. 2014. Posttranscriptional RNA modifications: playing metabolic games in a cell's chemical Legoland. Chem Biol 21: 174-185.
51. Helm M, Motorin Y. 2017. Detecting RNA modifications in the epitran-scriptome: predict and validate. Nat Rev Genet 18: 275-291.
52. Hengesbach M, Meusburger M, Lyko F, Helm M. 2008. Use of DNAzymes for site-specific analysis of ribonucleotide modifications. RNA 14: 180-187.
53. Hess ME, Hess S, Meyer KD, Verhagen LA, Koch L, Bronneke HS, Dietrich MO, Jordan SD, Saletore Y, Elemento O, et al. 2013. The fat mass and obesity associated gene (Fto) regulates activity of the dopaminergic midbrain circuitry. Nat Neurosci 16: 1042-1048.
54. Hideyama T, Kwak S. 2011. When does ALS start? ADAR2-GluA2 hypothesis for the etiology of sporadic ALS. Front Mol Neurosci 4: 33.
55. Hideyama T, Yamashita T, Aizawa H, Tsuji S, Kakita A, Takahashi H, Kwak S. 2012. Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons. Neurobiol Dis 45: 1121-1128.
56. Hussain S, Bashir ZI. 2015. The epitranscriptome in modulating spatio-temporal RNA translation in neuronal post-synaptic function. Front Cell Neurosci 9: 420.
57. Hussain S, Aleksic J, Blanco S, Dietmann S, Frye M. 2013. Characterizing 5-methylcytosine in the mammalian epitranscrip-tome. Genome Biol 14: 215.
58. Jain M, Fiddes IT, Miga KH, Olsen HE, Paten B, Akeson M. 2015. Improved data analysis for the MinION nanopore sequencer. Nat Methods 12: 351-356.
59. Jain M, Koren S, Quick J, Rand AC, Sasani TA, Tyson JR, Beggs AD, Dilthey AT, Fiddes IT, Malla S, et al. 2017. Nanopore sequencing and assembly of a human genome with ultra-long reads. bioRxiv. doi: 10.1101/128835.
60. 6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol 7: 885-887.
61. Karijolich J, Yu YT. 2010. Spliceosomal snRNA modifications and their function. RNA Biol 7: 192-204.
62. Keith G. 1995. Mobilities of modified ribonucleotides on two-dimensional cellulose thin-layer chromatography. Biochimie 77: 142-144.
63. Khoddami V, Cairns BR. 2013. Identification of direct targets and modified bases of RNA cytosine methyltransferases. Nat Biotechnol 31: 458-464.
64. Klassen R, Ciftci A, Funk J, Bruch A, Butter F, Schaffrath R. 2016. tRNA anticodon loop modifications ensure protein homeostasis and cell morphogenesis in yeast. Nucleic Acids Res 44: 10946-10959.
65. Klungland A, Dahl JA. 2014. Dynamic RNA modifications in disease. Curr Opin Genet Dev 26: 47-52.
66. Konig J, Zarnack K, Rot G, Curk T, Kayikci M, Zupan B, Turner DJ, Luscombe NM, Ule J. 2010. iCLIP reveals the function of hnRNP particles in splicing at individual nucleotide resolution. Nat Struct Mol Biol 17: 909-915.
67. Larrieu D, Britton S, Demir M, Rodriguez R, Jackson SP. 2014. Chemical inhibition of NAT10 corrects defects of laminopathic cells. Science 344: 527-532.
68. Lasram K, Ben Halim N, Benrahma H, Mediene-Benchekor S, Arfa I, Hsouna S, Kefi R, Jamoussi H, Ben Ammar S, Bahri S, et al. 2015. Contribution of CDKAL1 rs7756992 and IGF2BP2 rs4402960 polymorphisms in type 2 diabetes, diabetic complications, obesity risk and hypertension in the Tunisian population. J Diabetes 7: 102-113.
69. Laver T, Harrison J, O'Neill PA, Moore K, Farbos A, Paszkiewicz K, Studholme DJ. 2015. Assessing the performance of the Oxford Nanopore Technologies MinION. Biomol Detect Quantif 3: 1-8.
70. Lemmens R, Moore MJ, Al-Chalabi A, Brown RH Jr, Robberecht W. 2010. RNA metabolism and the pathogenesis of motor neuron diseases. Trends Neurosci 33: 249-258.
71. 6A modulates neuronal functions and sex determination in Drosophila. Nature 540: 242-247.
72. Li S, Limbach PA. 2012. Method for comparative analysis of ribonucleic acids using isotope labeling and mass spectrometry. Anal Chem 84: 8607-8613.
73. Li S, Mason CE. 2014. The pivotal regulatory landscape of RNA modifications. Annu Rev Genomics Hum Genet 15: 127-150.
74. Li X, Xiong X, Yi C. 2016. Epitranscriptome sequencing technologies: decoding RNA modifications. Nat Methods 14: 23-31.
75. 6Am throughout the transcriptome. Nat Methods 12: 767-772.
76. Liu F, Clark W, Luo G, Wang X, Fu Y, Wei J, Wang X, Hao Z, Dai Q, Zheng G, et al. 2016. ALKBH1-mediated tRNA demethylation regulates translation. Cell 167: 1897.
77. Locke JM, Wei FY, TomizawaK,Weedon MN, Harries LW. 2015.Acau-tionary tale: the non-causal association between type 2 diabetes risk SNP, rs7756992, and levels of non-coding RNA, CDKAL1-v1. Diabetologia 58: 745-748.
78. Loman NJ, Watson M. 2015. Successful test launch for nanopore sequencing. Nat Methods 12: 303-304.
79. Loman NJ, Quick J, Simpson JT. 2015. A complete bacterial genome assembled de novo using only nanopore sequencing data. Nat Methods 12: 733-735.
80. Lu H, Giordano F, Ning Z. 2016. Oxford nanopore MinION sequencing and genome assembly. Genomics Proteomics Bioinformatics 14: 265-279.
81. Machnicka MA, Milanowska K, Osman Oglou O, Purta E, Kurkowska M, Olchowik A, Januszewski W, Kalinowski S, Dunin-Horkawicz S, Rother KM, et al. 2013. MODOMICS: a database of RNA modification pathways-2013 update. Nucleic Acids Res 41: D262-D267.
82. Martinez FJ, Lee JH, Lee JE, Blanco S, Nickerson E, Gabriel S, Frye M, Al-Gazali L, Gleeson JG. 2012. Whole exome sequencing identifies a splicing mutation in NSUN2 as a cause of a Dubowitz-like syndrome. J Med Genet 49: 380-385.
83. Mattick JS. 2010. RNA as the substrate for epigenome-environment interactions: RNA guidance of epigenetic processes and the expansion of RNA editing in animals underpins development, phenotypic plasticity, learning, and cognition. Bioessays 32: 548-552.
84. Mattick JS. 2011. The central role of RNA in human development and cognition. FEBS Lett 585: 1600-1616.
85. Mattick JS, Mehler MF. 2008. RNA editing, DNA recoding and the evolution of human cognition. Trends Neurosci 31: 227-233.
86. 6Am in the 5′ cap controls mRNA stability. Nature 541: 371-375.
87. McIntyre ABR, Alexander N, Burton AS, Castro-Wallace S, Chiu CY, John KK, Stahl SE, Li S, Mason CE. 2017. Nanopore detection of bacterial DNA base modifications. bioRxiv. doi: 10.1101/127100
88. Mercer TR, Mattick JS. 2013. Structure and function of long noncoding RNAs in epigenetic regulation. Nat Struct Mol Biol 20: 300-307.
89. 6A readers, writers, and erasers. Annu Rev Cell Dev Biol 33: 1.
90. Meyer KD, Saletore Y, Zumbo P, Elemento O, Mason CE, Jaffrey SR. 2012. Comprehensive analysis of mRNA methylation reveals enrichment in 3′ UTRs and near stop codons. Cell 149: 1635-1646.
91. Morris KV, Mattick JS. 2014. The rise of regulatory RNA. Nat Rev Genet 15: 423-437.
92. Motorin Y, Muller S, Behm-Ansmant I, Branlant C. 2007. Identification of modified residues in RNAs by reverse transcription-based methods. Methods Enzymol 425: 21-53.
93. Nainar S, Marshall PR, Tyler CR, Spitale RC, Bredy TW. 2016. Evolving insights into RNA modifications and their functional diversity in the brain. Nat Neurosci 19: 1292-1298.
94. Najmabadi H, Hu H, Garshasbi M, Zemojtel T, Abedini SS, Chen W, Hosseini M, Behjati F, Haas S, Jamali P, et al. 2011. Deep sequencing reveals 50 novel genes for recessive cognitive disorders. Nature 478: 57-63.
95. Nedialkova DD, Leidel SA. 2015. Optimization of codon translation rates via tRNA modifications maintains proteome integrity. Cell 161: 1606-1618.
96. Nikcevic I, Wyrzykiewicz TK, Limbach PA. 2011. Detecting low-level synthesis impurities in modified phosphorothioate oligonucleotides using liquid chromatography - high resolution mass spectrometry. Int J Mass Spectrom 304: 98-104.
97. Novoa EM, Mason CE, Mattick JS. 2017. Charting the unknown epi-transcriptome. Nat Rev Mol Cell Biol 18: 339-340.
98. Patil A, Chan CT, Dyavaiah M, Rooney JP, Dedon PC, Begley TJ. 2012. Translational infidelity-induced protein stress results from a deficiency in Trm9-catalyzed tRNA modifications. RNA Biol 9: 990-1001.
99. Paul MS, Bass BL. 1998. Inosine exists in mRNA at tissue-specific levels and is most abundant in brain mRNA. EMBO J 17: 1120-1127.
100. Paz-Yaacov N, Levanon EY, Nevo E, Kinar Y, Harmelin A, Jacob-Hirsch J, Amariglio N, Eisenberg E, Rechavi G. 2010. Adenosine-to-inosine RNA editing shapes transcriptome diversity in primates. Proc Natl Acad Sci 107: 12174-12179.
101. Picardi E, Manzari C, Mastropasqua F, Aiello I, D'Erchia AM, Pesole G. 2015. Profiling RNA editing in human tissues: towards the inosi-nome Atlas. Sci Rep 5: 14941.
102. Quick J, Loman NJ, Duraffour S, Simpson JT, Severi E, Cowley L, Bore JA, Koundouno R, Dudas G, Mikhail A, et al. 2016. Realtime, portable genome sequencing for Ebola surveillance. Nature 530: 228-232.
103. Quick J, Grubaugh ND, Pullan ST, Claro IM, Smith AD, Gangavarapu K, Oliveira G, Robles-Sikisaka R, Rogers TF, Beutler NA, et al. 2017. Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples. Nat Protoc 12: 1261-1276.
104. Qureshi IA, Mattick JS, Mehler MF. 2010. Long non-coding RNAs in nervous system function and disease. Brain Res 1338: 20-35.
105. Ramaswami G, Zhang R, Piskol R, Keegan LP, Deng P, O'Connell MA, Li JB. 2013. Identifying RNA editing sites using RNA sequencing data alone. Nat Methods 10: 128-132.
106. Rand AC, Jain M, Eizenga JM, Musselman-Brown A, Olsen HE, Akeson M, Paten B. 2017. Mapping DNA methylation with high-throughput nanopore sequencing. Nat Methods 14: 411-413.
107. Reddy R, Henning D, Epstein P, Busch H. 1981. Primary and secondary structure of U2 snRNA. Nucleic Acids Res 9: 5645-5658.
108. Rhoads A, Au KF. 2015. PacBio sequencing and its applications. Genomics Proteomics Bioinformatics 13: 278-289.
109. Rodriguez V, Chen Y, Elkahloun A, Dutra A, Pak E, ChandrasekharappaS.2007. Chromosome 8 BAC array comparative genomic hybridization and expression analysis identify amplification and overexpression of TRMT12 in breast cancer. Genes Chromosomes Cancer 46: 694-707.
110. Ryvkin P, Leung YY, Silverman IM, Childress M, Valladares O, Dragomir I, Gregory BD, Wang LS. 2013. HAMR: high-throughput annotation of modified ribonucleotides. RNA 19: 1684-1692.
111. Saletore Y, Meyer K, Korlach J, Vilfan ID, Jaffrey S, Mason CE. 2012. The birth of the Epitranscriptome: deciphering the function of RNA modifications. Genome Biol 13: 175.
112. Sarin LP, Leidel SA. 2014. Modify or die? - RNA modification defects in metazoans. RNA Biol 11: 1555-1567.
113. Sarkozy P, Jobbágy Á, Antal P. 2017. Calling homopolymer stretches from raw nanopore reads by analyzing k-mer dwell times. In EMBEC & NBC 2017: joint conference of the European Medical and Biological Engineering Conference (EMBEC) and the Nordic-Baltic Conference on Biomedical Engineering and Medical Physics (NBC), Tampere, Finland, June 2017 (ed. Eskola H, et al.), pp. 241-244. Springer Singapore, Singapore.
114. Sasaki S, Yamashita T, Kwak S. 2015. Autophagy in spinal motor neurons of conditional ADAR2-knockout mice: an implication for a role of calcium in increased autophagy flux in ALS. Neurosci Lett 598: 79-84.
115. Sawyer SL, Emerman M, Malik HS. 2004. Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. PLoS Biol 2: E275.
116. Schaefer M, Pollex T, Hanna K, Lyko F. 2009. RNA cytosine methylation analysis by bisulfite sequencing. Nucleic Acids Res 37: e12.
117. Schaffrath R, Leidel SA. 2017. Wobble uridine modifications-a reason to live, a reason to die?! RNA Biol 23: 1-14.
118. Schwartz S. 2016. Cracking the epitranscriptome. RNA 22: 169-174.
119. Schwartz S, Agarwala SD, Mumbach MR, Jovanovic M, Mertins P, Shishkin A, Tabach Y, Mikkelsen TS, Satija R, Ruvkun G, et al. 2013. High-resolution mapping reveals a conserved, widespread, dynamic mRNA methylation program in yeast meiosis. Cell 155: 1409-1421.
120. Schwartz S, Bernstein DA, Mumbach MR, Jovanovic M, Herbst RH, Leon-Ricardo BX, Engreitz JM, Guttman M, Satija R, Lander ES, et al. 2014a. Transcriptome-wide mapping reveals widespread dynamic-regulated pseudouridylation of ncRNA and mRNA. Cell 159: 148-162.
121. 6A writers reveals two distinct classes of mRNA methylation at internal and 5′ sites. Cell Rep 8: 284-296.
122. Shafik A, Schumann U, Evers M, Sibbritt T, Preiss T. 2016. The emerging epitranscriptomics of long noncoding RNAs. Biochim Biophys Acta 1859: 59-70.
123. 7G46 methylation and causes a distinct form of microcephalic primordial dwarfism. Genome Biol 16: 210.
124. Sharma U, Conine CC, Shea JM, Boskovic A, Derr AG, Bing XY, Belleannee C, Kucukural A, Serra RW, Sun F, et al. 2016. Biogenesis and function of tRNA fragments during sperm maturation and fertilization in mammals. Science 351: 391-396.
125. Simpson JT, Workman RE, Zuzarte PC, David M, Dursi LJ, Timp W. 2017. Detecting DNA cytosine methylation using nanopore sequencing. Nat Methods 14: 407-410.
126. Smith AM, Jain M, Mulroney L, Garalde DR, Akeson M. 2017. Reading canonical and modified nucleotides in 16S ribosomal RNA using nanopore direct RNA sequencing. bioRxiv. doi: 10.1101/132274.
127. Squires JE, Patel HR, Nousch M, Sibbritt T, Humphreys DT, Parker BJ, Suter CM, Preiss T. 2012. Widespread occurrence of 5-methylcyto-sine in human coding and non-coding RNA. Nucleic Acids Res 40: 5023-5033.
128. Stoiber M, Brown J. 2017. BasecRAWller: streaming nanopore basecall-ing directly from raw signal. bioRxiv. doi: 10.1101/133058.
129. Stoiber MH, Quick J, Egan R, Lee JE, Celniker SE, Neely R, Loman N, Pennacchio L, Brown JB. 2016. De novo identification of DNA modifications enabled by genome-guided nanopore signal processing. bioRxiv. doi: 10.1101/094672.
130. Su D, Chan CT, Gu C, Lim KS, Chionh YH, McBee ME, Russell BS, Babu IR, Begley TJ, Dedon PC. 2014. Quantitative analysis of ribo-nucleoside modifications in tRNA by HPLC-coupled mass spec-trometry. Nat Protoc 9: 828-841.
131. Tomaselli S, Galeano F, Alon S, Raho S, Galardi S, Polito VA, Presutti C, Vincenti S, Eisenberg E, Locatelli F, et al. 2015. Modulation of microRNA editing, expression and processing by ADAR2 deaminase in glioblastoma. Genome Biol 16: 5.
132. Torres AG, Batlle E, Ribas de Pouplana L. 2014. Role of tRNA modifications in human diseases. Trends Mol Med 20: 306-314.
133. Tuorto F, Liebers R, Musch T, Schaefer M, Hofmann S, Kellner S, Frye M, Helm M, Stoecklin G, Lyko F. 2012. RNA cytosine methyl-ation by Dnmt2 and NSun2 promotes tRNA stability and protein synthesis. Nat Struct Mol Biol 19: 900-905.
134. Wang X, He C. 2014. Dynamic RNA modifications in posttranscription-al regulation. Mol Cell 56: 5-12.
135. 6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells. Nat Cell Biol 16: 191-198.
136. Wang X, Zhao BS, Roundtree IA, Lu Z, Han D, Ma H, Weng X, Chen K, Shi H, He C. 2015. N -methyladenosine modulates messenger RNA translation efficiency. Cell 161: 1388-1399.
137. Wu Q, Niebuhr E, Yang H, Hansen L. 2005. Determination of the 'critical region' for cat-like cry of Cri-du-chat syndrome and analysis of candidate genes by quantitative PCR. Eur J Hum Genet 13: 475-485.
138. Yan M, Wang Y, Hu Y, Feng Y, Dai C, Wu J, Wu D, Zhang F, Zhai Q. 2013. A high-throughput quantitative approach reveals more small RNA modifications in mouse liver and their correlation with diabetes. Anal Chem 85: 12173-12181.
139. Yi J, Gao R, Chen Y, Yang Z, Han P, Zhang H, Dou Y, Liu W, Wang W, Du G, et al. 2016. Overexpression of NSUN2 by DNA hypomethylation is associated with metastatic progression in human breast cancer. Oncotarget 8: 20751-20765.
140. Zhao X, Yu YT. 2004. Detection and quantitation of RNA base modifications. RNA 10: 996-1002.
141. Zhao BS, Roundtree IA, He C. 2016. Post-transcriptional gene regulation by mRNA modifications. Nat Rev Mol Cell Biol 18: 31-42.
142. 6A-dependent maternal mRNA clearance facilitates zebra-fish maternal-to-zygotic transition. Nature 542: 475-478.
143. Zheng G, Dahl JA, Niu Y, Fedorcsak P, Huang CM, Li CJ, Vagbo CB, Shi Y, Wang WL, Song SH, et al. 2013. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol Cell 49: 18-29.
144. Zinshteyn B, Gilbert WV. 2013. Loss of a conserved tRNA anticodon modification perturbs cellular signaling. PLoS Genet 9: e1003675.